| Literature DB >> 36128862 |
Min-Kyung Yeo1, Go Eun Bae1, Dong-Hyun Kim1, In-Ock Seong1, Kwang-Sun Suh1.
Abstract
BACKGROUND: Gastric-type endocervical adenocarcinoma (GEA) is unrelated to human papillomavirus (HPV) infection and is clinically aggressive compared with HPV-associated usual-type endocervical adenocarcinoma (UEA). The cytological diagnosis falls short of a definitive diagnosis of GEA and is often categorized as atypical glandular cells (AGCs). To improve cytologic recognition, cytological findings of HPV-independent GEA were analyzed and the results compared with HPV-associated UEA.Entities:
Keywords: Cervix uteri; Cytology; Gastric type adenocarcinoma; Papanicolaou smear
Year: 2022 PMID: 36128862 PMCID: PMC9510040 DOI: 10.4132/jptm.2022.07.05
Source DB: PubMed Journal: J Pathol Transl Med ISSN: 2383-7837
Clinicopathologic findings of GEA and UEA
| Clinicopathologic findings | GEA (n = 10) | UEA (n = 12) |
|---|---|---|
| Age (yr) | ||
| Mean ± SD | 61.7 ± 11.9 | 45.3 ± 10.9 |
| Range | 48–80 | 31–68 |
| Type of surgical treatment | ||
| Radical hysterectomy | 7 (70.0) | 8 (66.7) |
| Total hysterectomy | 0 | 3 (25.0) |
| Trachelectomy | 1 (10.0) | 0 |
| Conization | 2 (20.0) | 1 (8.3) |
| FIGO stage | ||
| I | 1 (10.0) | 9 (75.0) |
| II | 4 (40.0) | 1 (8.3) |
| III | 3 (30.0) | 2 (16.7) |
| IV | 2 (20.0) | 0 |
| Human papillomavirus status | ||
| High-risk HPV | 0 | 12 (100) |
| Not detected | 10 (100) | 0 |
| p16 expression | ||
| Block positive | 1 (10.0) | 12 (100) |
| Patchy positive/negative | 9 (90.0) | 0 |
| p53 expression | ||
| Diffuse strong positive | 5 (50.0) | 0 |
| Complete loss (null) | 1 (10.0) | 0 |
| Patchy positive | 4 (40.0) | 12 (100) |
| Follow-up results | ||
| No evidence of disease | 2 (20.0) | 9 (75.0) |
| Alive with disease | 3 (30.0) | 0 (0.0) |
| Died of disease | 4 (40.0) | 0 (0.0) |
| Died of other disease | 0 | 1[ |
| Not available | 1 (10.0) | 2 (16.7) |
Values are presented as number (%) unless otherwise indicated.
GEA, gastric-type endocervical adenocarcinoma; UEA, usual-type endocervical adenocarcinoma; SD, standard deviation; FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus.
Died of stomach cancer.
Clinical and immunohistochemical findings of 10 cases of gastric-type endocervical adenocarcinoma
| Case No. | Age (yr) | Preparation type | Cytologic diagnosis | Type of surgery | FIGO stage | HPV | p16 | p53 | MUC-6 | Adjuvant treatment | Follow-up (mo) | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| CS | LBP | ||||||||||||
| 1 | 48 | + | + | AIS | Trachelectomy | IVA | − | − | + | + | CC | 20 | DOD |
| 2 | 80 | + | + | Adenocarcinoma | RH | IIB | − | − | Wild | −[ | RT | 38 | DOD |
| 3 | 52 | + | + | AGC | RH | IIIC1 | − | − | Wild | + | CCRT | 48 | AWD |
| 4 | 58 | + | + | Adenocarcinoma | RH | IVA | −[ | − | + | + | CC | 23 | DOD |
| 5 | 54 | + | + | Adenocarcinoma | RH | IIA1 | − | + | + | + | NA | FU loss | NA |
| 6 | 54 | NA | NA | NA | Conization | IIIC1 | − | − | Wild | + | CCRT | 17 | DOD |
| 7 | 78 | NA | + | Adenocarcinoma | Conization | IIA2 | − | − | + | −[ | RT | 21 | NED |
| 8 | 63 | NA | + | AGC | RH | IB1 | − | − | Null | + | CCRT | 21 | NED |
| 9 | 76 | NA | + | AGC | RH | IIB | − | − | + | + | RT | 10 | AWD |
| 10 | 54 | NA | NA | NA | RH | IIIC1 | − | − | Wild | + | CCRT | 10 | AWD |
CS, conventional smear; LBP, liquid-based preparation; FIGO, International Federation of Gynecology and Obstetrics; HPV, human papillomavirus; AIS, adenocarcinoma in situ; CC, combined chemotherapy; DOD, died of disease; RH, radical hysterectomy; RT, radiotherapy; AGC, atypical glandular cells, favor neoplastic; CCRT, combined chemotherapy and radiotherapy; AWD, alive with disease; NA, not available; FU, follow-up; NED, no evidence of disease.
Pale pinkish-red cytoplasmic neutral mucin on Alcian blue/PAS special staining;
High risk HPV DNA in situ hybridization; +, p16, block-type positivity; +, p53, overexpression.
Fig. 1Human papillomavirus-independent gastric-type endocervical adenocarcinoma. Irregular angulated glands invading the cervical stroma (A). Tumor cells show negative immunohistochemical reactions for p16 (B), aberrant nuclear overexpression for p53 (C), and positivity for MUC6 (D). Atypical glands with voluminous clear cytoplasm and distinct cell borders (E). The cytoplasm contains neutral mucins that stain pale pinkish-red on Alcian blue/periodic acid–Schiff special staining in contrast to the dark purple of acid mucins of the normal endocervix (inset) (F).
Fig. 2Human papillomavirus–associated usual-type endocervical adenocarcinoma. Irregular confluent glands composed of mucin-depleted cells with pseudostratified, hyperchromatic nuclei (A). Tumor cells show a block-type immunohistochemical reaction for p16 (B).
Cytologic findings of gastric-type adenocarcinoma (GEA) and usual-type endocervical adenocarcinoma (UEA)
| Cytologic finding | GEA (n=8) | UEA (n=12) | p-value |
|---|---|---|---|
| Mucinous background | .058 | ||
| Absent | 2 (25.0) | 2 (16.7) | |
| Focal | 2 (25.0) | 9 (75.0) | |
| Extensive | 4 (50.0) | 1 (8.3) | |
| Architecture | |||
| Monolayered honeycomb-like sheet | .002 | ||
| Absent | 0 | 6 (50.0) | |
| Focal | 1 (12.5) | 5 (41.7) | |
| Extensive | 7 (87.5) | 1 (8.3) | |
| 3-dimensional clusters | .010 | ||
| Absent | 0 | 0 | |
| Focal | 5 (62.5) | 1 (8.3) | |
| Extensive | 3 (37.5) | 11 (91.7) | |
| Feathering | .189 | ||
| Absent | 3 (37.5) | 3 (25.0) | |
| Focal | 5 (62.5) | 5 (41.7) | |
| Extensive | 0 | 4 (33.3) | |
| Nuclei | |||
| Vesicular nuclei | .057 | ||
| Absent | 0 (0.0) | 1 (8.3) | |
| Focal | 0 (0.0) | 5 (41.7) | |
| Extensive | 8 (100.0) | 6 (50.0) | |
| Hyperchromasia | .082 | ||
| Absent | 2 (25.0) | 0 | |
| Focal | 6 (75.0) | 9 (75.0) | |
| Extensive | 0 (0.0) | 3 (25.0) | |
| Nuclear groove | .230 | ||
| Absent | 0 (0.0) | 3 (25.0) | |
| Focal | 6 (75.0) | 8 (66.7) | |
| Extensive | 2 (25.0) | 1 (8.3) | |
| Nucleoli | .146 | ||
| Absent | 0 (0.0) | 3 (25.0) | |
| Focal | 3 (37.5) | 6 (50.0) | |
| Extensive | 5 (62.5) | 3 (25.0) | |
| Intranuclear pseudoinclusion | .761 | ||
| Absent | 7 (87.5) | 11 (91.7) | |
| Focal | 1 (12.5) | 1 (8.3) | |
| Extensive | 0 | 0 | |
| Cytoplasm | |||
| Vacuolar/granular | .001 | ||
| Absent | 0 | 2 (16.7) | |
| Focal | 0 | 8 (66.7) | |
| Extensive | 8 (100) | 2 (16.7) | |
| Golden-brown mucin | .089 | ||
| Absent | 3 (37.5) | 10 (83.3) | |
| Focal | 4 (50.0) | 2 (16.7) | |
| Extensive | 1 (12.5) | 0 | |
| Neutrophils | .461 | ||
| Absent | 0 | 1 (8.3) | |
| Focal | 2 (25.0) | 5 (41.7) | |
| Extensive | 6 (75.0) | 6 (50.0) | |
Fig. 3Human papillomavirus–independent gastric-type endocervical adenocarcinoma. Monolayered honeycomb-like sheets of atypical endocervical cells in a mucinous background (open arrowhead) (A, conventional smear; B, liquid-based preparation). Usual-type endocervical adenocarcinoma. Three-dimensional clusters of hyperchromatic nuclei (C, conventional smear), feathering clusters (empty arrow), and occasional intranuclear cytoplasmic pseudoinclusions (inset, arrow) (D, conventional smear).
Fig. 4Human papillomavirus-independent gastric-type endocervical adenocarcinoma. Vesicular nuclei showing nuclear grooves (open arrowhead) (A, liquid-based preparation [LBP]). Atypical tumor cells having abundant vacuolar cytoplasm with golden-brown mucin (open arrowhead) in contrast with pink normal endocervical-type mucin (arrow) (B, conventional smear). Abundant foamy cytoplasm with distinct cell borders and golden-brown mucin (open arrowhead) (C, LBP) and intracytoplasmic neutrophils (arrow) (D, LBP).
Literature review summary of the pretreatment cytologic diagnosis of GEA cases
| Kawakami et al. [ | Lu et al. [ | Schwock et al. [ | Ryu et al. [ | This study | Total, n (%) | |
|---|---|---|---|---|---|---|
| No. of cases | 14 | 11 | 15 | 8 | 8 | 56 (100) |
| Preparation type | CS | LBC | CS and LBC | CS and LBC | CS and/or LBC | CS and/or LBC |
| TBS classification | ||||||
| Unsatisfactory | 0 | 1 | 0 | 0 | 0 | 1 (1.8) |
| NILM | 0 | 5 | 5 | 0 | 0 | 10 (17.9) |
| AGC | 3 | 4 | 2 | 4 | 3 | 16 (28.6) |
| AIS | 0 | 0 | 1 | 1 | 1 | 3 (5.4) |
| HSIL | 0 | 1 | 0 | 0 | 0 | 1 (1.8) |
| Adenocarcinoma | 11 | 0 | 7 | 3 | 4 | 25 (44.6) |
GEA, gastric-type endocervical adenocarcinoma; CS, conventional smear; LBC, liquid-based cytology; TBS, The Bethesda System; NILM, negative for intraepithelial lesion or malignancy; AGC, atypical glandular cells, not otherwise specified and favor adenocarcinoma; AIS, adenocarcinoma in situ; HSIL, high-grade squamous intraepithelial lesion.